arrow
Back
P

Paul Malik

ionis pharmaceuticals inc.

12H-index
26Paper Count
572Citation Count
Published Papers 10
Publication Date
A Modeling Investigation of the CYP1A Drug Interactions of Riluzole
err2025-09-16
err0
errOAAI
errMalik, Paul; Mian, Paola; Andrews, Jinsy; Rosebraugh, Matthew; Ajroud-Driss, Senda
errShare
errSave
Pharmacokinetics of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor in Special Cystic Fibrosis Populations: A Systematic Review
err2025-05-21
err0
errOAAI
errElzinga, Femke A.; Malik, Paul R. V.; Akkerman, Onno W.; Rottier, Bart L.; van der Vaart, Hester; Touw, Daan J.; Koppelman, Gerard H.; Mian, Paola
errShare
errSave
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia
err2024-05-10
err3
errOAAI
errPalic, Semra; Chu, Wan-Yu; Sundar, Shyam; Mondal, Dinesh; Das, Pradeep; Pandey, Krishna; Raja, Sheeraz; Rijal, Suman; Roseboom, Ignace C.; Hamadeh, Abdullah; Malik, Paul R. V.; Beijnen, Jos H.; Huitema, Alwin D. R.; Sjogren, Erik; Alves, Fabiana; Dorlo, Thomas P. C.
errShare
errSave
Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation
err2019-04-12
err40
errOAAI
errAborig, Mohamed; Malik, Paul R. V.; Nambiar, Shruti; Chelle, Pierre; Darko, Johnson; Mutsaers, Anthony; Edginton, Andrea N.; Fleck, Andre; Osei, Ernest; Wettig, Shawn
errShare
errSave
Pharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer
err2017-09-18
err40
PREAI
errMalik, Paul; Phipps, Colin; Edginton, Andrea; Blay, Jonathan
errShare
errSave
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis
err2013-04-18
err82
errOAAI
errRiecher-Roessler, A.; Rybakowski, J. K.; Pflueger, M. O.; Beyrau, R.; Kahn, R. S.; Malik, P.; Fleischhacker, W. W.
errShare
errSave